OncoMed

Article summary

OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. , the company had 83 employees. OncoMed's drug discovery work focuses on developing "targeted antibodies against cancer stem cells". The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company. OncoMed went public in 2013 and was listed on NASDAQ under the stock symbol OMED. In April 2019 the company was acquired by Mereo BioPharma and delisted from the Nasdaq.

Key claims

1. date of foundation: 2004 — source: Wikipedia · confidence 0.95
2. date of foundation: 2004 — source: Wikipedia · confidence 0.95
3. employees: 83 employees — source: Wikipedia · confidence 0.95

Discussion questions

1. Summarise the article in your own words. Which single claim would you verify first, and why?
2. The record states that the date of foundation is "2004". What evidence would count against this claim?
3. The record states that the date of foundation is "2004". What evidence would count against this claim?
4. The record states that the employees is "83 employees". What evidence would count against this claim?
5. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
6. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

1. Wikipedia https://en.wikipedia.org/w/index.php?oldid=1357086527